| Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease LTJ Hickson, LGPL Prata, SA Bobart, TK Evans, N Giorgadze, SK Hashmi, ... EBioMedicine 47, 446-456, 2019 | 1071* | 2019 |
| Clinical features and outcomes of immune checkpoint inhibitor–associated AKI: a multicenter study FB Cortazar, ZA Kibbelaar, IG Glezerman, A Abudayyeh, O Mamlouk, ... Journal of the American Society of Nephrology 31 (2), 435-446, 2020 | 341 | 2020 |
| The enzyme CD38 (a NAD glycohydrolase, EC 3.2. 2.5) is necessary for the development of diet‐induced obesity MTP Barbosa, SM Soares, CM Novak, D Sinclair, JA Levine, P Aksoy, ... The FASEB Journal 21 (13), 3629-3639, 2007 | 300 | 2007 |
| Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy S Sethi, L Zand, N Leung, RJH Smith, D Jevremonic, SS Herrmann, ... Clinical Journal of the American Society of Nephrology 5 (5), 770-782, 2010 | 236 | 2010 |
| Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38 P Aksoy, C Escande, TA White, M Thompson, S Soares, JC Benech, ... Biochemical and biophysical research communications 349 (1), 353-359, 2006 | 218 | 2006 |
| Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events RM Touyz, SMS Herrmann, J Herrmann Journal of the American Society of Hypertension 12 (6), 409-425, 2018 | 203 | 2018 |
| Acute kidney injury in patients treated with immune checkpoint inhibitors S Gupta, SAP Short, ME Sise, JM Prosek, SM Madhavan, MJ Soler, ... Journal for immunotherapy of cancer 9 (10), e003467, 2021 | 169 | 2021 |
| Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis S Manohar, P Kompotiatis, C Thongprayoon, W Cheungpasitporn, ... Nephrology Dialysis Transplantation 34 (1), 108-117, 2019 | 167 | 2019 |
| Associations of rotational shift work and night shift status with hypertension: a systematic review and meta-analysis S Manohar, C Thongprayoon, W Cheungpasitporn, MA Mao, ... Journal of hypertension 35 (10), 1929-1937, 2017 | 162 | 2017 |
| Autologous mesenchymal stem cells increase cortical perfusion in renovascular disease A Saad, AB Dietz, SMS Herrmann, LTJ Hickson, JF Glockner, ... Journal of the American Society of Nephrology 28 (9), 2777-2785, 2017 | 159 | 2017 |
| A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis A Eirin, Z Li, X Zhang, JD Krier, JR Woollard, XY Zhu, H Tang, ... Hypertension 60 (5), 1242-1249, 2012 | 148 | 2012 |
| NAADP as a second messenger: neither CD38 nor base-exchange reaction are necessary for in vivo generation of NAADP in myometrial cells S Soares, M Thompson, T White, A Isbell, M Yamasaki, Y Prakash, ... American Journal of Physiology-Cell Physiology 292 (1), C227-C239, 2007 | 127 | 2007 |
| Myeloproliferative neoplasms cause glomerulopathy SM Said, N Leung, S Sethi, LD Cornell, ME Fidler, JP Grande, ... Kidney international 80 (7), 753-759, 2011 | 122 | 2011 |
| Renovascular hypertension SM Herrmann, SC Textor Endocrinology and Metabolism Clinics 48 (4), 765-778, 2019 | 116 | 2019 |
| Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients SM Soares, FC Fervenza, DJ Lager, MA Gertz, FG Cosio, N Leung American journal of kidney diseases 52 (6), 1079-1083, 2008 | 112 | 2008 |
| Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation SMS Herrmann, MA Gertz, MD Stegall, A Dispenzieri, FC Cosio, S Kumar, ... Nephrology Dialysis Transplantation 26 (6), 2032-2036, 2011 | 109 | 2011 |
| Hypertension and prohypertensive antineoplastic therapies in cancer patients DCH Van Dorst, SJH Dobbin, KB Neves, J Herrmann, SM Herrmann, ... Circulation research 128 (7), 1040-1061, 2021 | 108 | 2021 |
| Phase 2a clinical trial of mitochondrial protection (elamipretide) during stent revascularization in patients with atherosclerotic renal artery stenosis A Saad, SMS Herrmann, A Eirin, CM Ferguson, JF Glockner, H Bjarnason, ... Circulation: Cardiovascular Interventions 10 (9), e005487, 2017 | 104 | 2017 |
| Current concepts in the treatment of renovascular hypertension SM Herrmann, SC Textor American journal of hypertension 31 (2), 139-149, 2018 | 101 | 2018 |
| Immune checkpoint inhibitors and immune-related adverse renal events SM Herrmann, MA Perazella Kidney international reports 5 (8), 1139-1148, 2020 | 100 | 2020 |
